COVID treatment via Plasma therapy: ICMR gives nod to GMC Amritsar
Punjab Medical Education and Research Minister O P Soni said that the patients infected with coronavirus would be soon treated with the plasma therapy in the Government Medical College (GMC).
Advertisement
Chandigarh - The Indian Council of Medical Research (ICMR) has given approval to the Government Medical College Amritsar to treat the patients of COVID-19 with plasma therapy.
Stating this here on Friday, Punjab Medical Education and Research Minister O P Soni said that the patients infected with coronavirus would be soon treated with the plasma therapy in the Government Medical College (GMC).
Read Also: COVID-19 positive RML Dean undergoes plasma therapy in Delhi
Giving details, he said that all the requisite preparedness had already been completed to start this therapy within next few days.
Read Also: Move ICMR on potential COVID-19 curing drug: Madras HC directs doctor
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.